AU2002236527A1 - Nutrient supplements and methods for treating autism and for preventing the onset of autism - Google Patents

Nutrient supplements and methods for treating autism and for preventing the onset of autism

Info

Publication number
AU2002236527A1
AU2002236527A1 AU2002236527A AU3652702A AU2002236527A1 AU 2002236527 A1 AU2002236527 A1 AU 2002236527A1 AU 2002236527 A AU2002236527 A AU 2002236527A AU 3652702 A AU3652702 A AU 3652702A AU 2002236527 A1 AU2002236527 A1 AU 2002236527A1
Authority
AU
Australia
Prior art keywords
autism
onset
preventing
methods
nutrient supplements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002236527A
Inventor
Anjum Iona Usman
William John Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Research Institute
Original Assignee
Health Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Institute filed Critical Health Research Institute
Publication of AU2002236527A1 publication Critical patent/AU2002236527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002236527A 2000-11-30 2001-11-30 Nutrient supplements and methods for treating autism and for preventing the onset of autism Abandoned AU2002236527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25040400P 2000-11-30 2000-11-30
US60/250,404 2000-11-30
PCT/US2001/044912 WO2002043507A2 (en) 2000-11-30 2001-11-30 Nutrient supplements and methods for treating autism and for preventing the onset of autism

Publications (1)

Publication Number Publication Date
AU2002236527A1 true AU2002236527A1 (en) 2002-06-11

Family

ID=22947590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002236527A Abandoned AU2002236527A1 (en) 2000-11-30 2001-11-30 Nutrient supplements and methods for treating autism and for preventing the onset of autism

Country Status (3)

Country Link
US (3) US20020155170A1 (en)
AU (1) AU2002236527A1 (en)
WO (1) WO2002043507A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002236527A1 (en) * 2000-11-30 2002-06-11 The Health Research Institute Nutrient supplements and methods for treating autism and for preventing the onset of autism
US8691765B2 (en) 2002-06-13 2014-04-08 University Of Tasmania Metallothionein based neuronal therapeutic and therapeutic methods
AU2003233259B2 (en) * 2002-06-13 2008-08-28 University Of Tasmania Metallothionein based neuronal therapeutic and therapeutic methods
AUPS295802A0 (en) * 2002-06-13 2002-07-04 University Of Tasmania Metallothionein based neuronal therapeutic and therapeutic methods
US7617932B2 (en) 2003-09-19 2009-11-17 Diabetes Diagnostics, Inc. Medical device package, kit and associated methods
US20070053970A1 (en) * 2005-05-25 2007-03-08 Guilford F T Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway
ES2246737B1 (en) * 2005-06-09 2006-12-01 Jose Juan Rodriguez Jerez "PHARMACEUTICAL COMPOSITION INCLUDING LISINA AND CORRESPONDING USES".
EP1993607A4 (en) * 2006-01-10 2012-03-28 Pipex Inc Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
US20100055083A1 (en) * 2006-10-18 2010-03-04 Ray Edward Kowalski Encapsulation of heat and moisture sensitive substances
GB0624879D0 (en) * 2006-12-14 2007-01-24 Shs Int Ltd Treatment of pervasive development disorders
EP2131679B1 (en) 2007-02-22 2019-03-27 Children's Hospital & Research Center at Oakland Fatty acid formulations and methods of use thereof
US20090028800A1 (en) * 2007-07-27 2009-01-29 Peeples William H Method of Treating Postpartum Depression and Aggression
US8652545B2 (en) * 2008-02-13 2014-02-18 Reverta Health Solutions LLC Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children
WO2010027266A1 (en) * 2008-09-05 2010-03-11 Van De Langenberg, Hendrikus Theodorus Ardina Hubertus Means and methods for counteracting neurological disorders
EP3827815B1 (en) 2008-09-10 2023-09-06 PTC Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US9034834B2 (en) 2008-11-04 2015-05-19 Vymedic, Llc Antiviral supplement formulations
EA201200054A1 (en) * 2009-06-25 2012-05-30 Эмпэр Лайф Сайнсиз, Инк. TREATMENT OF TOKOTRIENOLS OR EXTRACTS, RICH TOKOTRIENOLS, PERVASIVE DEVELOPMENT DISORDERS
JP2013507394A (en) * 2009-10-09 2013-03-04 プロセラ インコーポレイテッド Compositions and methods comprising Pediococcus for reducing at least one symptom associated with an autism spectrum disorder in a human diagnosed with an autism spectrum disorder
US20120045416A1 (en) * 2010-08-23 2012-02-23 Donna Louise Sullivan Nutritional therapy method and dietary supplement food to restore compromised, ileal lymphoid nodular hyperplasia in autistic children
WO2012050895A1 (en) 2010-09-28 2012-04-19 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US9931365B2 (en) 2010-09-28 2018-04-03 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US9442092B2 (en) 2011-06-20 2016-09-13 Kerry Lane Methods for treatment of autism
KR101110271B1 (en) * 2011-07-14 2012-02-15 팜드림주식회사 Dairy products of containing functional alginic acid bead and manufacturing method thereof
BR112014015245A8 (en) * 2011-12-21 2017-07-04 Colgate Palmolive Co Methods and Products for Diagnosing and Treating Heat Disease
WO2013139861A1 (en) 2012-03-20 2013-09-26 Luc Montagnier Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
US20140072671A1 (en) * 2012-06-29 2014-03-13 Adam Auerbach Multi-component oral delivery systems and uses thereof
MX2013003636A (en) 2013-03-27 2014-09-29 Palsgaard Ind De Mexico S De R L De C V Food supplement for people with down syndrome, autism spectrum disorder and/or attention deficit disorder with or without hyperactivity.
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
US20150073023A1 (en) 2013-09-09 2015-03-12 Alcobra Ltd. Method Of Treating Fragile X Syndrome And Related Disorders
TW201606304A (en) * 2013-09-09 2016-02-16 亞克柏拉有限公司 Methods of determining response to therapy
US20150174079A1 (en) * 2013-12-24 2015-06-25 Food for Health International, LLC Lozenges with silver nanoparticles
US20170231938A1 (en) * 2014-10-09 2017-08-17 Albert Crum Protective metallothionein analog compounds, their compositions and use thereof in the treatment of pathogenic diseases
CN104548099B (en) * 2015-01-12 2018-03-30 陶燃 A kind of antidepressant composition and its application
JP6905527B2 (en) 2015-12-17 2021-07-21 ピーティーシー セラピューティクス， インコーポレイテッド Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amino 1,4-benzoquinone derivatives for treating oxidative stress disorders
EP3395341A4 (en) * 2015-12-21 2019-08-07 Nanjing Jianrong Bio-Technology Co., Ltd. Composition for treating motor neuron diseases and use thereof
US20230158084A1 (en) * 2018-01-05 2023-05-25 California Institute Of Technology Probiotics, metabolites, and uses thereof
CN108272808B (en) * 2018-01-22 2019-09-10 董淑霞 A kind of pharmaceutical composition and its vina with antitumor action
IT202000009700A1 (en) * 2020-05-04 2021-11-04 Parthenogen Sagl COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS PRODUCTION OF HYDROGEN SULFIDE (H2S)
CN111983098B (en) * 2020-08-28 2023-03-21 中山大学附属第七医院(深圳) Application of intestinal microorganism metabolite in preparation of autism diagnosis kit
US11854684B2 (en) 2020-12-29 2023-12-26 Kpn Innovations, Llc. Methods and systems for nourishment refinement using psychiatric markers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9105986A (en) * 1990-02-05 1992-11-10 Univ Texas TIME-RELEASE FORMULATION OF VITAMINS, MINERALS AND OTHER BENEFICIAL SUPPLEMENTS
CA2089607C (en) * 1992-11-05 1997-11-04 Ranjit K. Chandra Nutritional supplement for the elderly
IT1291113B1 (en) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS
US5976579A (en) * 1997-07-03 1999-11-02 Mclean; Linsey Nutritional supplement for the prevention and treatment of excessive intestinal permeability
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
CA2328197C (en) * 1998-04-14 2007-11-20 The General Hospital Corporation Methods for treating neuropsychiatric disorders
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
US6245360B1 (en) * 1998-06-26 2001-06-12 John S. Markowitz Nutritional supplement
AU4988000A (en) * 1999-05-07 2000-11-21 Trustees Of Tufts College Immune stimulating dietary supplement and methods of use thereof
WO2000067576A1 (en) 1999-05-12 2000-11-16 The Uab Research Foundation Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
AU8003800A (en) * 1999-10-08 2001-04-23 Joyce Corinne Bechthold Methods and compositions for treating neurobehavioral disorders
US20010055645A1 (en) * 2000-02-16 2001-12-27 Flook Laura A. Caffeinated fruit juices
US6399114B2 (en) * 2000-05-26 2002-06-04 C & D Foreman, Inc. Nutritional system for nervous system disorders
AU2002236527A1 (en) * 2000-11-30 2002-06-11 The Health Research Institute Nutrient supplements and methods for treating autism and for preventing the onset of autism

Also Published As

Publication number Publication date
US7232575B2 (en) 2007-06-19
US20020155170A1 (en) 2002-10-24
US20070020343A1 (en) 2007-01-25
WO2002043507A3 (en) 2003-03-06
WO2002043507A2 (en) 2002-06-06
US7534450B2 (en) 2009-05-19
US20070224290A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
AU2002236527A1 (en) Nutrient supplements and methods for treating autism and for preventing the onset of autism
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU5763900A (en) Methods of enriching for and identifying polymorphisms
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2001255655A1 (en) Treatment analysis systems and methods
IL148786A0 (en) Methods and microorganisms for production of panto-compounds
AU2002345612A1 (en) Ultrasound-fluoroscopic seed therapy system and method
AU2002215261A1 (en) Method and arrangement for treatment of fluid
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2001286983A1 (en) Method of treatment
AU2001255638A1 (en) Systems and methods for dental treatment planning
AU2001259817A1 (en) Methods of and compounds for inhibiting calpains
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU2002211359A1 (en) Stem cell-based methods for preventing and treating tumor
AU2420101A (en) Method and composition for the treatment of pain
AU2001262177A1 (en) Method of treatment
AU2001286489A1 (en) Process for the purification of iosoctane and/or diisobutylene
AU1567301A (en) Tablets comprising micro-organisms and method for preparation of the tablets
AU5097099A (en) Methods and compositions for cancer treatment